Eysuvis Approved for Dry Eye Disease
Results from 4 clinical trials showed that treatment with Eysuvis was associated with significant improvements in both the signs and symptoms of dry eye disease.
Ophthalmic Disorders
Cyclosporine Eyedrops Under Review for Vernal Keratoconjunctivitis
Vernal keratoconjunctivitis is a rare allergic eye disease that affects the pediatric population and results in severe inflammation of the surface of the eye.
Preservative-Free Alaway Gets FDA Approval for OTC Use
The new formulation does not contain benzalkonium chloride.
Cystadrops Now Available for Patients With Cystinosis
The Food and Drug Administration approved Cystadrops in August 2020.
Levodopa Benefits Neovascular Age-Related Macular Degeneration
Levodopa is safe and well-tolerated, improves visual outcomes, and delays anti-VEGF treatment.
Cystadrops Approved to Treat Corneal Crystal Deposits in Cystinosis
Cystinosis is a rare, multisystem genetic disorder caused by an accumulation of cystine crystals throughout the body, including the eyes.
FDA Warns of Risks Associated With Intraocular Use of Moxifloxacin
According to the Agency, 29 reports of TASS were identified following a search of the FDA Adverse Event Reporting System database through December 19, 2019.
EyeArt Autonomous AI System Cleared for Diabetic Retinopathy Screening
EyeArt is the first FDA-cleared AI technology for autonomous detection of more than mild diabetic retinopathy and vision-threatening diabetic retinopathy.
New Drug Product: Durysta
This slideshow shows drug information for Durysta. Click here for the complete Durysta monograph.
Glaucoma Patients Worry About Managing Disease During Pandemic
Delayed or canceled appointments during lockdown causing the greatest concern.
